InsidersTradesSigma
Follow the 凯普生物 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 凯普生物 has published 3 public disclosures. Market capitalisation: €3.5bn. The latest transaction was reported on 9 January 2026 (Purchase). Among the most active insiders: 谢龙旭. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
凯普生物 es una empresa centrada en el sector de la salud y farmacéutico, especializada en el desarrollo de soluciones biofarmacéuticas. Cotiza en el mercado XSHE.